CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer.
Saved in:
| Title: | CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer. |
|---|---|
| Authors: | Selvakumar SC; Centre for Cellular and Molecular Research, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, 600077, India., Preethi KA; Centre for Cellular and Molecular Research, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, 600077, India., Ross K; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK., Tusubira D; Biochemistry Department, Mbarara University of Science and Technology, Mbarara, Uganda. dtusubira@must.ac.ug., Khan MWA; Department of Chemistry, College of Sciences, University of Ha'il, Ha'il, 2440, Saudi Arabia., Mani P; Department of Biotechnology, Annai College of Arts and Science, Kumbakonam, Tamilnadu, India., Rao TN; Department of Chemistry, Krishna University, Machilipatnam, Andhra Pradesh, 521001, India., Sekar D; Centre for Cellular and Molecular Research, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, 600077, India. duraimku@gmail.com. |
| Source: | Molecular cancer [Mol Cancer] 2022 Mar 24; Vol. 21 (1), pp. 83. Date of Electronic Publication: 2022 Mar 24. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1476-4598 |
|---|---|
| DOI: | 10.1186/s12943-022-01565-1 |
